Home » Topics » BioWorld Science

BioWorld Science
RSS

Norovirus VLP vaccine TAK-214 immunogenic, well tolerated in phase II study

May 24, 2019

Amgen discloses APLNR agonists

May 24, 2019

ChemoCentryx divulges C5AR1 antagonists

May 24, 2019

GSK-2831781 begins phase II trial in moderate to severe active ulcerative colitis

May 24, 2019

Softer touch enhances drug delivery efficiency

May 24, 2019

FDA lifts target class clinical hold for lanifibranor

May 24, 2019

Modulation of PIK3C2B improves vaccination against influenza in PHIV children

May 24, 2019

Quinolinone SRI-34329 inhibits Venezuelan equine encephalitis virus at micromolar concentrations

May 24, 2019

APRINOIA Therapeutics awarded Michael J. Fox Foundation grant for Parkinson's research

May 24, 2019

Argenx expands pipeline with ARGX-117 and ARGX-118

May 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...